Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Cognat

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Metabolic Brain Disease|June 26, 2026
Plasma and CSF adiponectin levels in biomarker-confirmed Alzheimer's disease: A cross-sectional study in a tertiary memory clinicLouise Sindzingre, Théodore Decaix, Karl Gotze, et al.
Neurobiology of Disease|December 3, 2022
Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life studyKarl Götze, Agathe Vrillon, Elodie Bouaziz-Amar, et al.
Ebiomedicine|April 16, 2025
Dissection of blood-brain barrier dysfunction through CSF PDGFRβ and amyloid, tau, neuroinflammation, and synaptic CSF biomarkers in neurodegenerative disordersAgathe Vrillon, Nicholas J Ashton, Elodie Bouaziz-Amar, et al.
Plos One|May 16, 2019
Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tauAysha S Mohamed Lafirdeen, Emmanuel Cognat, Severine Sabia, et al.
Alzheimer'S Research & Therapy|July 3, 2024
Plasma biomarkers of amyloid, tau, axonal, and neuroinflammation pathologies in dementia with Lewy bodiesAgathe Vrillon, Olivier Bousiges, Karl Götze, et al.
The Journal of Prevention of Alzheimer'S Disease|January 29, 2025
MemScreen: A smartphone application for detection of mild cognitive impairment: A validation study: Smartphone App for MCI DetectionJulien Dumurgier, Claire Paquet, Jacques Hugon, et al.
Alzheimer'S Research & Therapy|January 21, 2026
Association of Alzheimer's disease biomarkers with malnutrition and altered body composition in cognitively impaired patients: a cross-sectional memory clinic studyKarl Götze, Agathe Vrillon, Manuel Sanchez, et al.
Frontiers in Psychology|July 18, 2022
Patients With Severe Alcohol-Related Cognitive Impairment Improve in Flexibility When Abstinence Is Maintained: A Comparative Study With Alzheimer's DiseaseVirgile Clergue-Duval, Thomas Barré, Emmanuel Cognat, et al.
Journal of Neuroscience Methods|June 2, 2022
A temporal classification method based on behavior time series data in patients with behavioral variant of frontotemporal dementia and apathyCaroline Peltier, François-Xavier Lejeune, Lars G T Jorgensen, et al.
Alzheimer'S Research & Therapy|October 19, 2024
Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting studyKarl Götze, Agathe Vrillon, Julien Dumurgier, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Metabolic Brain Disease|June 26, 2026
Plasma and CSF adiponectin levels in biomarker-confirmed Alzheimer's disease: A cross-sectional study in a tertiary memory clinicLouise Sindzingre, Théodore Decaix, Karl Gotze, et al.
Neurobiology of Disease|December 3, 2022
Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life studyKarl Götze, Agathe Vrillon, Elodie Bouaziz-Amar, et al.
Ebiomedicine|April 16, 2025
Dissection of blood-brain barrier dysfunction through CSF PDGFRβ and amyloid, tau, neuroinflammation, and synaptic CSF biomarkers in neurodegenerative disordersAgathe Vrillon, Nicholas J Ashton, Elodie Bouaziz-Amar, et al.
Plos One|May 16, 2019
Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tauAysha S Mohamed Lafirdeen, Emmanuel Cognat, Severine Sabia, et al.
Alzheimer'S Research & Therapy|July 3, 2024
Plasma biomarkers of amyloid, tau, axonal, and neuroinflammation pathologies in dementia with Lewy bodiesAgathe Vrillon, Olivier Bousiges, Karl Götze, et al.
The Journal of Prevention of Alzheimer'S Disease|January 29, 2025
MemScreen: A smartphone application for detection of mild cognitive impairment: A validation study: Smartphone App for MCI DetectionJulien Dumurgier, Claire Paquet, Jacques Hugon, et al.
Alzheimer'S Research & Therapy|January 21, 2026
Association of Alzheimer's disease biomarkers with malnutrition and altered body composition in cognitively impaired patients: a cross-sectional memory clinic studyKarl Götze, Agathe Vrillon, Manuel Sanchez, et al.
Frontiers in Psychology|July 18, 2022
Patients With Severe Alcohol-Related Cognitive Impairment Improve in Flexibility When Abstinence Is Maintained: A Comparative Study With Alzheimer's DiseaseVirgile Clergue-Duval, Thomas Barré, Emmanuel Cognat, et al.
Journal of Neuroscience Methods|June 2, 2022
A temporal classification method based on behavior time series data in patients with behavioral variant of frontotemporal dementia and apathyCaroline Peltier, François-Xavier Lejeune, Lars G T Jorgensen, et al.
Alzheimer'S Research & Therapy|October 19, 2024
Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting studyKarl Götze, Agathe Vrillon, Julien Dumurgier, et al.
Pageof 9